Your browser doesn't support javascript.
loading
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial.
Pignata, S; Scambia, G; Savarese, A; Breda, E; Sorio, R; Pisano, C; Lorusso, D; Cognetti, F; Vernaglia Lombardi, A; Gebbia, V; Scollo, P; Morabito, A; Signoriello, G; Perrone, F.
Affiliation
  • Pignata S; Oncologia Medica B, Istituto Nazionale Tumori, Naples, Italy. sandro.pignata@fondazionepascale.it
Oncology ; 76(1): 49-54, 2009.
Article in En | MEDLINE | ID: mdl-19039248
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Polyethylene Glycols / Antineoplastic Combined Chemotherapy Protocols / Doxorubicin / Carboplatin / Paclitaxel / Neoplasms, Glandular and Epithelial / Antibiotics, Antineoplastic Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Oncology Year: 2009 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Polyethylene Glycols / Antineoplastic Combined Chemotherapy Protocols / Doxorubicin / Carboplatin / Paclitaxel / Neoplasms, Glandular and Epithelial / Antibiotics, Antineoplastic Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Oncology Year: 2009 Type: Article Affiliation country: Italy